annual interest expense:
$30.60M-$13.50M(-30.61%)Summary
- As of today (May 21, 2025), VRTX annual interest expense is $30.60 million, with the most recent change of -$13.50 million (-30.61%) on December 31, 2024.
- During the last 3 years, VRTX annual interest expense has fallen by -$30.90 million (-50.24%).
- VRTX annual interest expense is now -63.66% below its all-time high of $84.21 million, reached on December 31, 2015.
Performance
VRTX Interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly interest expense:
$3.00M+$200.00K(+7.14%)Summary
- As of today (May 21, 2025), VRTX quarterly interest expense is $3.00 million, with the most recent change of +$200.00 thousand (+7.14%) on March 31, 2025.
- Over the past year, VRTX quarterly interest expense has dropped by -$7.40 million (-71.15%).
- VRTX quarterly interest expense is now -87.65% below its all-time high of $24.30 million, reached on December 31, 2017.
Performance
VRTX quarterly interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM interest expense:
$23.20M-$7.40M(-24.18%)Summary
- As of today (May 21, 2025), VRTX TTM interest expense is $23.20 million, with the most recent change of -$7.40 million (-24.18%) on March 31, 2025.
- Over the past year, VRTX TTM interest expense has dropped by -$19.90 million (-46.17%).
- VRTX TTM interest expense is now -72.62% below its all-time high of $84.73 million, reached on September 30, 2015.
Performance
VRTX TTM interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Interest expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
VRTX Interest expense Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -30.6% | -71.2% | -46.2% |
3 y3 years | -50.2% | -79.9% | -61.8% |
5 y5 years | -47.7% | -78.8% | -59.8% |
VRTX Interest expense Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -50.2% | at low | -79.9% | +7.1% | -61.8% | at low |
5 y | 5-year | -50.2% | at low | -81.6% | +7.1% | -63.0% | at low |
alltime | all time | -63.7% | +132.0% | -87.7% | +3057.9% | -72.6% | +586.8% |
VRTX Interest expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $3.00M(+7.1%) | $23.20M(-24.2%) |
Dec 2024 | $30.60M(-30.6%) | $2.80M(-62.7%) | $30.60M(-20.3%) |
Sep 2024 | - | $7.50M(-24.2%) | $38.40M(-8.1%) |
Jun 2024 | - | $9.90M(-4.8%) | $41.80M(-3.0%) |
Mar 2024 | - | $10.40M(-1.9%) | $43.10M(-2.3%) |
Dec 2023 | $44.10M(-19.5%) | $10.60M(-2.8%) | $44.10M(-2.2%) |
Sep 2023 | - | $10.90M(-2.7%) | $45.10M(-5.8%) |
Jun 2023 | - | $11.20M(-1.8%) | $47.90M(-6.6%) |
Mar 2023 | - | $11.40M(-1.7%) | $51.30M(-6.4%) |
Dec 2022 | $54.80M(-10.9%) | $11.60M(-15.3%) | $54.80M(-6.0%) |
Sep 2022 | - | $13.70M(-6.2%) | $58.30M(-2.5%) |
Jun 2022 | - | $14.60M(-2.0%) | $59.80M(-1.5%) |
Mar 2022 | - | $14.90M(-1.3%) | $60.70M(-1.3%) |
Dec 2021 | $61.50M(+5.7%) | $15.10M(-0.7%) | $61.50M(-2.0%) |
Sep 2021 | - | $15.20M(-1.9%) | $62.74M(+2.2%) |
Jun 2021 | - | $15.50M(-1.3%) | $61.39M(+2.7%) |
Mar 2021 | - | $15.70M(-3.9%) | $59.76M(+2.7%) |
Dec 2020 | $58.20M(-0.5%) | $16.34M(+17.9%) | $58.20M(+3.7%) |
Sep 2020 | - | $13.86M(-0.1%) | $56.11M(-1.2%) |
Jun 2020 | - | $13.87M(-1.9%) | $56.80M(-1.7%) |
Mar 2020 | - | $14.14M(-0.8%) | $57.77M(-1.3%) |
Dec 2019 | $58.50M(-19.3%) | $14.25M(-2.1%) | $58.50M(-7.1%) |
Sep 2019 | - | $14.55M(-1.9%) | $63.00M(-6.2%) |
Jun 2019 | - | $14.84M(-0.2%) | $67.14M(-4.7%) |
Mar 2019 | - | $14.87M(-20.7%) | $70.45M(-2.8%) |
Dec 2018 | $72.47M(+4.6%) | $18.74M(+0.3%) | $72.47M(-7.1%) |
Sep 2018 | - | $18.69M(+2.9%) | $78.02M(+7.0%) |
Jun 2018 | - | $18.16M(+7.5%) | $72.91M(+5.0%) |
Mar 2018 | - | $16.89M(-30.5%) | $69.42M(+0.2%) |
Dec 2017 | $69.30M | $24.30M(+79.0%) | $69.30M(+5.9%) |
Sep 2017 | - | $13.57M(-7.4%) | $65.44M(-9.1%) |
Jun 2017 | - | $14.66M(-12.5%) | $72.01M(-7.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2017 | - | $16.77M(-18.0%) | $77.50M(-4.8%) |
Dec 2016 | $81.43M(-3.3%) | $20.44M(+1.5%) | $81.43M(-0.3%) |
Sep 2016 | - | $20.14M(-0.1%) | $81.65M(-1.2%) |
Jun 2016 | - | $20.16M(-2.6%) | $82.64M(-1.1%) |
Mar 2016 | - | $20.70M(+0.2%) | $83.60M(-0.7%) |
Dec 2015 | $84.21M(+15.6%) | $20.65M(-2.3%) | $84.21M(-0.6%) |
Sep 2015 | - | $21.13M(+0.1%) | $84.73M(+0.9%) |
Jun 2015 | - | $21.11M(-0.9%) | $83.98M(+7.0%) |
Mar 2015 | - | $21.31M(+0.6%) | $78.45M(+7.7%) |
Dec 2014 | $72.86M(+217.8%) | $21.18M(+3.9%) | $72.86M(+13.0%) |
Sep 2014 | - | $20.38M(+30.8%) | $64.50M(+45.9%) |
Jun 2014 | - | $15.59M(-0.8%) | $44.21M(+25.7%) |
Mar 2014 | - | $15.72M(+22.6%) | $35.18M(+53.4%) |
Dec 2013 | $22.93M(+52.4%) | $12.82M(>+9900.0%) | $22.93M(+126.8%) |
Sep 2013 | - | $95.00K(-98.5%) | $10.11M(+0.9%) |
Jun 2013 | - | $6.55M(+89.1%) | $10.02M(+189.1%) |
Mar 2013 | - | $3.46M(-15.5%) | $3.46M(-88.4%) |
Dec 2012 | $15.04M(-60.1%) | - | - |
Mar 2012 | - | $4.10M(-64.8%) | $29.78M(-21.0%) |
Dec 2011 | $37.68M(+95.5%) | $11.66M(+65.2%) | $37.68M(+11.8%) |
Sep 2011 | - | $7.06M(+1.4%) | $33.71M(+10.2%) |
Jun 2011 | - | $6.96M(-42.0%) | $30.60M(+12.0%) |
Mar 2011 | - | $12.00M(+56.1%) | $27.32M(+41.7%) |
Dec 2010 | $19.27M(+46.1%) | $7.69M(+94.5%) | $19.27M(+19.3%) |
Sep 2010 | - | $3.95M(+7.3%) | $16.15M(+14.3%) |
Jun 2010 | - | $3.68M(-6.9%) | $14.13M(+2.6%) |
Mar 2010 | - | $3.96M(-13.3%) | $13.77M(+4.4%) |
Dec 2009 | $13.19M(-2.1%) | $4.56M(+136.7%) | $13.19M(+52.9%) |
Sep 2009 | - | $1.93M(-42.0%) | $8.63M(+28.7%) |
Jun 2009 | - | $3.33M(-1.6%) | $6.70M(+98.4%) |
Mar 2009 | - | $3.38M | $3.38M |
Dec 2008 | $13.47M | - | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual interest expense?
- What is the all time high annual interest expense for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual interest expense year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly interest expense?
- What is the all time high quarterly interest expense for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly interest expense year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM interest expense?
- What is the all time high TTM interest expense for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM interest expense year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual interest expense?
The current annual interest expense of VRTX is $30.60M
What is the all time high annual interest expense for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual interest expense is $84.21M
What is Vertex Pharmaceuticals Incorporated annual interest expense year-on-year change?
Over the past year, VRTX annual interest expense has changed by -$13.50M (-30.61%)
What is Vertex Pharmaceuticals Incorporated quarterly interest expense?
The current quarterly interest expense of VRTX is $3.00M
What is the all time high quarterly interest expense for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly interest expense is $24.30M
What is Vertex Pharmaceuticals Incorporated quarterly interest expense year-on-year change?
Over the past year, VRTX quarterly interest expense has changed by -$7.40M (-71.15%)
What is Vertex Pharmaceuticals Incorporated TTM interest expense?
The current TTM interest expense of VRTX is $23.20M
What is the all time high TTM interest expense for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM interest expense is $84.73M
What is Vertex Pharmaceuticals Incorporated TTM interest expense year-on-year change?
Over the past year, VRTX TTM interest expense has changed by -$19.90M (-46.17%)